CLINICAL_TRIALS
research
· 2025-09-09
Clinical Trial Update: PHP and Immunotherapy in Metastasized UM [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating PHP in combination with immunotherapy for metastatic uveal melanoma; the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Leiden University Medical Center | Conditions: Uveal Melanoma, Metastatic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING